AIV Logo AIV Assistant

Loading...

Logo Novacyt S.A. - ALNOV.PA Open Novacyt S.A. in new tab

0.45 EUR
EPS
-0.47
P/B
0.78
ROE
-51.22
Beta
0.28

0.4515 EUR

0.452 EUR

Daily: +0.00%
Key Metrics

EPS: -0.47

Book Value: 0.58

Price to Book: 0.78

Debt/Equity: 26.81

% Insiders: 0.061%

Growth

Revenue Growth: -0.02%

Estimates

Forward P/E: 1.73

Forward EPS: 0.26

DCF Valuation

Tweak assumptions to recompute fair value for Novacyt S.A. (ALNOV.PA)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Logo About Novacyt S.A. - (ALNOV.PA)

Country: United Kingdom

Sector: Health Care

Website: http://www.novacyt.com

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.

Exchange Ticker
FRA (Germany) NYZ.F
STU (Germany) NYZ.SG
LSE (United Kingdom) NCYT.L
PNK (United States) NVYTF
PAR (France) ALNOV.PA

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion